We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
ProterixBio is a provider of molecular assessments to transform the care of patients with chronic respiratory disease. Our initial focus is COPD, which is the 3rd leading cause of death worldwide and contributes >$40B of direct healthcare spending annually in the U.S. alone. ProterixBio’s proprietary technology uses multiple blood-based biomarkers combined in an algorithm to characterize a patient’s disease state. Results from multiple clinical studies presented major respiratory conferences demonstrate improvement over symptoms and history alone for assessing propensity for future exacerbations. We are starting pilot studies with COPD management programs to target patient enrollment with the ultimate goal of reducing the number of ER visits and hospitalizations. The rapid expansion of value-based care programs managing chronically ill populations and the emergence of new targeted therapies within respiratory provide substantial opportunity for growth.